Everolimus
NDC 49884-159, Everolimus, tablet, from Par Health USA, LLC.
- Product NDC
- 49884-159
- Status
- Listed
- Labeler
- Par Health USA, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205775
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/49884-159 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EVEROLIMUS.5 mg/1
Pharmacologic classes
Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; mTOR Inhibitor Immunosuppressant [EPC]; mTOR Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 49884-159-02 | 49884015902 | 6 BLISTER PACK in 1 CARTON (49884-159-02) / 10 TABLET in 1 BLISTER PACK (49884-159-52) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/59cb86d5-8706-4619-b074-af253d3e0b68Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=49884-159NADAC price for package 49884015902
GET /v1/drugs/nadac/49884015902
Use it
Look up 49884-159 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/49884-159 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 49884-159. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.